Use of a COPD care pathway heightened the odds for a pulmonary rehabilitation referral and home discharge in hospitalized ...

Men and women with chronic obstructive pulmonary disease (COPD), bronchiectasis, and nontuberculous mycobacterial (NTM) lung ...

Measuring lung function earlier in life would help identify people at risk of developing chronic obstructive pulmonary disease (COPD) and allow for more timely interventions, according to a new study ...

Brensocatib, a DPP1 inhibitor, is the first FDA-approved therapy for non-cystic fibrosis bronchiectasis, showing significant clinical and structural benefits. The ASPEN trial demonstrated that ...

While over- and continuous exposure to air pollutants can cause irreversible lung damage and are a risk factor for chronic ...

Here’s our weekly round-up of what illnesses are spreading the most in Metro Detroit communities, according to our local ...

Adults hospitalized for acute COPD exacerbation faced elevated odds for all-cause mortality and ICU admission if they had end-stage renal disease and were on dialysis, according to data presented at ...

A new lung clinic opening in Halifax at the end of November is hoping to tackle long waitlists for breathing tests, while ...

F32 grants from the National Institutes of Health (NIH) help early-career physician-scientists launch research careers, ...

November 14, 2025 / RedChip Companies will air interviews with Connect Biopharma Holdings Limited (Nasdaq:CNTB) and Bimergen Energy Corp. (OCTQB:BESS) on the RedChip Small Stocks, Big Money™ show, a ...

A leader in interventional pulmonology and advanced bronchoscopy, Dr. Gildea joins Olympus after 22 years with the Cleveland ...

November is Lung Cancer Awareness Month, a time to raise awareness and educate the public about the leading cause of cancer ...